Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism

Endocrine

Volumn 39, Issue 3, 2011, Pages 283-287

  Faggiano, A ^a   Di Somma, C ^a   Ramundo, V ^b   Severino, R ^b   Vuolo, L ^b   Coppola, A ^c   Panico, F ^d   Savastano, S ^b   Lombardi, G ^b   Colao, A ^b   Gasperi, M ^e  

^a IRCCS SDN   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Castellammare di Stabia   (Italy)

^d Hospital of Nola   (Italy)

^e UNIVERSITY OF MOLISE   (Italy)

Author keywords

Alendronate; Bone mineral density; Cinacalcet; Hypercalcemia; Primary hyperparathyroidism

Indexed keywords

ALENDRONIC ACID; CALCIUM; CINACALCET; COLECALCIFEROL; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; HYPERCALCEMIA; KIDNEY COLIC; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PHOSPHATE BLOOD LEVEL; PHOSPHATE URINE LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SEX RATIO; SUBSTITUTION THERAPY; VITAMIN D DEFICIENCY;

EID: 79959958133     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9459-0     Document Type: Article

References (16)

1. S. Adami, C. Marcocci, D. Gatti, Epidemiology of primary hyperparathyroidism in Europe. J. Bone Miner. Res. 17, N18-N23 (2002) (Pubitemid 35222308)
2. A. K. Chan, Q. Y. Duh, M. H. Katz, A. E. Siperstein, O. H. Clark, Ann. Surg. 22, 402-412(1995)
3. AACE/AAES, Endocr. Pract. 11, 49-54(2005)
4. J. P. Bilezikian, J. T. Potts Jr, G.-H. Fuleihan, M. Kleerekoper, R. Neer, M. Peacock, J. Rastad, S. J. Silverberg, R. Udelsman, S. A. Wells Jr., J. Bone Miner. Res. 17, N2-N11 (2002)
5. D. M. Shoback, J. P. Bilezikian, S. A. Turner, L. C. McCary, M. D. Guo, M. Peacock, J. Clin. Endocrinol. Metab. 88, 5644-5649(2003)
6. M. Peacock, J. P. Bilezikian, P. S. Klassen, M. D. Guo, S. A. Turner, D. Shoback, J. Clin. Endocrinol. Metab. 90, 135-141(2005)
7. S. J. Silverberg, M. R. Rubin, C. Faiman, M. Peacock, D. M. Shoback, R. C. Smallridge, L. E. Schwanauer, K. A. Olson, P. Klassen, J. P. Bilezikian, J. Clin. Endocrinol. Metab. 92, 3803-3808(2007)
8. C. Marcocci, P. Chanson, D. Shoback, J. Bilezikian, L. Fernandez-Cruz, J. Orgiazzi, C. Henzen, S. Cheng, L. R. Sterling, J. Lu, M. Peacock, J. Clin. Endocrinol. Metab. 94, 2766-2772(2009)
9. C. C. Chow, W. B. Chan, J. K. Li, N. N. Chan, M. H. Chan, G. T. Ko, K. W. Lo, C. S. Cockram, J. Clin. Endocrinol. Metab. 88, 581-587(2003)
10. M. Rossini, D. Gatti, G. Isaia, L. Sartori, V. Braga, S. Adami, J. Bone Miner. Res. 16, 113-119(2001)
11. A. A. Khan, J. P. Bilezikian, A. W. Kung, M. M. Ahmed, S. J. Dubois, A. Y. Ho, D. Schussheim, M. R. Rubin, A. M. Shaikh, S. J. Silverberg, T. I. Standish, Z. Syed, Z. A. Syed, J. Clin. Endocrinol. Metab. 89, 3319-3325(2004)
12. H. K. Genant, C. Y. Wu, C. van Knijk, M. C. Nevitt, J. Bone Miner. Res. 8, 1137-1148(1993)
13. A. C. Ross, J. E. Manson, S. A. Abrams et al., J. Clin. Endocrinol. Metab. 96, 53-58(2011)
14. A. Falchetti, A. Cilotti, L. Vaggelli, L. Masi, A. Amedei, F. Cioppi, F. Tonelli, M. L. Brandi, Nat. Clin. Pract. Endocrinol. Metab. 4, 351-357(2008)
15. A. Khan, A. Grey, D. Shoback, J. Clin. Endocrinol. Metab. 94, 373-381(2009)
16. M. Peacock, M. A. Bolognese, M. Borofsky, S. Scumpia, L. R. Sterling, S. Cheng, D. Shoback, J. Clin. Endocrinol. Metab. 94, 4860-4867(2009)